HBK Investments’s Bioverativ Inc. Common Stock BIVV Stock Holding History

HBK Investments’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,522	Closed	-$567K	–	1233
2017 Q4	$567K	Sell	10,522 -67,613	-87%	-$3.7M	﹤0.01%	717
2017 Q3	$4.46M	Buy	78,135 +13,052	+20%	+$764K	0.03%	279
2017 Q2	$3.92M	Sell	65,083 -8,024	-11%	-$457K	0.02%	286
2017 Q1	$3.98M	Buy	+73,107	New	+$3.6M	0.03%	236

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

HBK Investments's BIVV Position: Q1 2018 in Review

HBK Investments sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,522 shares — an estimated $567K sold.

HBK Investments first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $4.46M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

HBK Investments reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
HBK Investments sold 10,522 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $567K.
HBK Investments first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
HBK Investments's Bioverativ Inc. Common Stock position peaked at $4.46M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on HBK Investments's 13F filing for Q1 2018, filed 15 May 2018.